The IFN-gamma allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplant
- PMID: 20565368
The IFN-gamma allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplant
Abstract
Objectives: Analysis of nonhistocompatibility leucocyte antigen functional genomics in stem cell transplant can lead to prediction of clinical outcomes in histocompatibility leucocyte antigen-matched sibling-transplant recipients. Some of the cytokine gene polymorphisms might be associated with severe, acute graft-versus-host disease after allogeneic stem cell transplant. We evaluated gene polymorphisms of IL-6 G-174C, TGF-beta T+869C, IL-4 C-590T, and IFN-alpha T+874A cytokines in bone marrow transplant patients.
Materials and methods: The amplification refractory mutation system-polymerase chain reaction ARMSPCR method was used to characterize IL-6 G-174C, TGF-beta T+869C, and IFN-alpha T+874A polymorphisms, and PCR-RFLP, using AvaII restriction enzyme, was done for IL-4 C-590T characterization in 35 bone marrow transplant patients. Acute graft-versus-host disease episodes were diagnosed according to EMBT criteria.
Results: Analysis showed that IFN-alpha +874T allele (P = .027, OR=0.198, 95% CI=0.049-0.801) was correlated to moderate-to-severe graft-versus-host disease. TGF-beta T+869C, IFN-alpha T+874A, IL-6 G-174C and IL-4 C-590T frequencies were not significantly different in the 2 graft-versus-host disease severity groups (P > .05).
Conclusions: According to the results, we concluded that the IFN-alpha T+874A gene polymorphism has a predictive value for severity of graft-versus-host disease after bone marrow transplant. High producer genotypes of IFN-alpha are genetic risk factors for development of graft-versus-host disease.
Similar articles
-
Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation.Bone Marrow Transplant. 2002 Nov;30(10):665-71. doi: 10.1038/sj.bmt.1703684. Bone Marrow Transplant. 2002. PMID: 12420205
-
A study of the impact of cytokine gene polymorphism in acute rejection of renal transplant recipients.Mol Biol Rep. 2012 Jan;39(1):509-15. doi: 10.1007/s11033-011-0765-7. Epub 2011 May 12. Mol Biol Rep. 2012. PMID: 21562768
-
Interleukin-10 gene polymorphism in bone marrow transplant recipients.Exp Clin Transplant. 2008 Mar;6(1):74-9. Exp Clin Transplant. 2008. PMID: 18405249
-
Genetic polymorphisms predicting the outcome of bone marrow transplants.Br J Haematol. 2004 Dec;127(5):479-90. doi: 10.1111/j.1365-2141.2004.05216.x. Br J Haematol. 2004. PMID: 15566351 Review.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
Cited by
-
Association of IL-6 promoter and IFN-γ gene polymorphisms with acute rejection of liver transplantation.Mol Biol Rep. 2011 Oct;38(7):4437-43. doi: 10.1007/s11033-010-0572-6. Epub 2010 Dec 4. Mol Biol Rep. 2011. PMID: 21132384
-
Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients.Clin Cancer Res. 2016 Jan 1;22(1):69-78. doi: 10.1158/1078-0432.CCR-15-1344. Epub 2015 Aug 18. Clin Cancer Res. 2016. PMID: 26286914 Free PMC article.
-
Association of IL-12 and TNF-α Polymorphisms with Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients.Int J Organ Transplant Med. 2019;10(1):37-45. Epub 2019 Feb 1. Int J Organ Transplant Med. 2019. PMID: 30891168 Free PMC article.
-
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.Blood Adv. 2018 Jul 24;2(14):1719-1737. doi: 10.1182/bloodadvances.2017011502. Blood Adv. 2018. PMID: 30030270 Free PMC article. Clinical Trial.
-
Transforming growth factor-β1 polymorphisms and graft-versus-host disease risk: a meta-analysis.Oncotarget. 2016 Jan 19;7(3):2455-61. doi: 10.18632/oncotarget.6289. Oncotarget. 2016. PMID: 26544732 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources